10x Genomics (TXG) EBIT Growth (3y) (2021 - 2026)

10x Genomics (TXG) EBIT Growth (3y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (3y) (Qtr)
1 Veeva Systems 29.34 Bn 22.03 Bn 662.02 Mn 64.34%
2 BrightSpring Health Services 13.49 Bn 12.59 Bn 482.22 Mn 33.06%
3 Healthequity 7.96 Bn 7.70 Bn 256.31 Mn 64.37%
4 10x Genomics 6.17 Bn 5.63 Bn 106.18 Mn 31.04%
5 Hinge Health 6.02 Bn 5.70 Bn 154.23 Mn -
6 MiniMed 4.19 Bn 3.89 Bn 480.00 Mn -
7 Waystar Holding 4.14 Bn 4.07 Bn 216.84 Mn -
8 Doximity 3.82 Bn 3.08 Bn 125.97 Mn -8.90%
9 Privia Health 3.10 Bn 2.73 Bn - 3.40%
10 Omnicell 1.81 Bn 1.57 Bn 140.36 Mn 39.83%

Historic Data

Download Data
DateValue
Mar 31, 2026 31.04%
Dec 31, 2025 5.42%
Sep 30, 2025 6.93%
Jun 30, 2025 35.31%
Mar 31, 2025 1.96%
Dec 31, 2024 -46.56%
Sep 30, 2024 -37.73%
Jun 30, 2024 -59.28%
Mar 31, 2024 -81.91%
Dec 31, 2023 48.73%
Sep 30, 2023 -13.25%
Jun 30, 2023 -17.14%
Mar 31, 2023 -37.76%
Dec 31, 2022 -41.92%
Sep 30, 2022 -63.83%
Jun 30, 2022 -82.63%
Mar 31, 2022 -139.58%
Dec 31, 2021 40.45%
Sep 30, 2021 -2.07%